ECM
BSX icon

Endurant Capital Management’s Boston Scientific BSX Stock Holding History

Endurant Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,108
Closed -$2.26M – 5
2023
Q4 		$2.26M Sell
39,108
-8,785
-18% -$469K 12.96% 1
2023
Q3 		$2.53M Sell
47,893
-13,098
-21% -$687K 2.27% 15
2023
Q2 		$3.3M Buy
+60,991
New +$3.19M 2.88% 12
2022
Q3 		– Sell
-418,165
Closed -$15.6M – 53
2022
Q2 		$15.6M Buy
+418,165
New +$17M 5.47% 3
2021
Q2 		– Sell
-158,702
Closed -$6.13M – 65
2021
Q1 		$6.13M Buy
+158,702
New +$6.01M 1.6% 26
2020
Q3 		– Sell
-106,338
Closed -$3.73M – 62
2020
Q2 		$3.73M Buy
+106,338
New +$3.83M 0.2% 28
2019
Q1 		– Sell
-30,560
Closed -$1.08M – 73
2018
Q4 		$1.08M Sell
30,560
-39,847
-57% -$1.45M 0.57% 36
2018
Q3 		$2.71M Sell
70,407
-2,434
-3% -$85K 1.21% 28
2018
Q2 		$2.38M Sell
72,841
-314,857
-81% -$9.5M 1.03% 27
2018
Q1 		$10.6M Buy
387,698
+45,100
+13% +$1.23M 3.96% 6
2017
Q4 		$8.49M Buy
342,598
+132,100
+63% +$3.64M 2.6% 13
2017
Q3 		$6.14M Buy
210,498
+82,800
+65% +$2.29M 1.86% 19
2017
Q2 		$3.54M Sell
127,698
-98,500
-44% -$2.61M 1% 32
2017
Q1 		$5.63M Sell
226,198
-106,000
-32% -$2.58M 1.81% 21
2016
Q4 		$7.18M Buy
332,198
+73,900
+29% +$1.61M 2.97% 9
2016
Q3 		$6.15M Sell
258,298
-108,700
-30% -$2.59M 2.28% 14
2016
Q2 		$8.58M Sell
366,998
-159,700
-30% -$3.45M 2.87% 11
2016
Q1 		$9.91M Buy
526,698
+250,600
+91% +$4.4M 3.21% 6
2015
Q4 		$5.09M Buy
276,098
+21,398
+8% +$383K 1.7% 21
2015
Q3 		$4.18M Buy
254,700
+109,600
+76% +$1.87M 1.4% 25
2015
Q2 		$2.57M Sell
145,100
-98,100
-40% -$1.75M 0.76% 41
2015
Q1 		$4.32M Buy
243,200
+29,900
+14% +$473K 1.43% 22
2014
Q4 		$2.83M Buy
+213,300
New +$2.73M 1.11% 29

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Endurant Capital Management's BSX Position: Q1 2024 in Review

Endurant Capital Management sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 39,108 shares — an estimated $2.26M sold.

Endurant Capital Management first reported a position in BSX in Q4 2014 and held it in 23 quarters. The position peaked at $15.6M in Q2 2022. 1,227 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Endurant Capital Management reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 39,108 Boston Scientific shares in Q1 2024, an estimated $2.26M.
  • Endurant Capital Management first reported a position in Boston Scientific in Q4 2014 and held it in 23 quarters.
  • Endurant Capital Management's Boston Scientific position peaked at $15.6M in Q2 2022.
  • 1,227 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.